Glenmark Pharma has advanced on USFDA nod

Glenmark Pharma has advanced on receiving US FDA approval for moexipril hydrochloride and hydrochlorothiazide tablets

The stock opened at Rs 245 and is now up at Rs 244, up 1% from its previous close. The counter has clocked volumes of 240,000 shares on the BSE.